Spots Global Cancer Trial Database for nilutamide
Every month we try and update this database with for nilutamide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00028769 | Prostate Cancer | bicalutamide estramustine etoposide flutamide goserelin leuprolide nilutamide paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | NCT01786265 | Prostate Adenoc... Recurrent Prost... | Abiraterone Ace... Bicalutamide Degarelix Flutamide Goserelin Aceta... Leuprolide Acet... Nilutamide Prednisone | 18 Years - | M.D. Anderson Cancer Center | |
| Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer | NCT00020254 | Prostate Cancer | aldesleukin recombinant fow... recombinant vac... recombinant vac... sargramostim nilutamide | 18 Years - | National Cancer Institute (NCI) | |
| Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | NCT00003653 | Prostate Cancer | bicalutamide buserelin cyproterone ace... flutamide goserelin leuprolide acet... nilutamide | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer | NCT00512668 | Adenocarcinoma ... Recurrent Prost... | leuprolide acet... goserelin aceta... bicalutamide nilutamide flutamide temsirolimus laboratory biom... | - | National Cancer Institute (NCI) | |
| Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer | NCT00918385 | Prostate Cancer | Nilutamide Dasatinib | 18 Years - | Duke University | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | NCT03678025 | Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin | 18 Years - | SWOG Cancer Research Network | |
| Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | NCT00002633 | Prostate Cancer | bicalutamide buserelin flutamide goserelin leuprolide acet... nilutamide orchiectomy radiation thera... | - 79 Years | Canadian Cancer Trials Group | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | NCT03678025 | Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin | 18 Years - | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
